Results 11,701-11,720 of 26,448 for speaker:David Cullinane
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: Has the board examined the extent to which challenge was provided? Two reports have examined where the process failures were. According to the Mazars report:It was noted in the GMP report dated 12 November 2018 that a key driver in the escalation of costs was the 2nd stage measurement process. The cost escalation noted in respect of this process was €142m. Anyone who examines where...
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: Was Mr. Quinn on the board at that time?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: I will stop Mr. Quinn there. Is that, in itself, not a problem?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: How was it that the board did not know? Where was the failure? Why did the board not become aware of this until the tail end of May 2018? What was the failure that led to circumstances in which the board did not find out until the tail end of May 2018? If things were working effectively, surely the board would have been aware much earlier. If it was not the board's fault, it was someone...
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: The board was being told it was a single point of failure. We are now being told by Mr. Quinn that they did not become aware of the escalating costs until the tail end. There was an obvious failure in process. How could it be that at the tail end, the board-----
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: One second. Sorry, I am not finished. The board, which was tasked with making sure of value for money and containing costs, did not become aware until the tail end. How did that happen?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: The design process-----
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: All of this has to go back to the overall project. According to page 18 of the Mazars report on the design, and as Mr. Quinn has outlined, "Design best estimate costs increased sharply in June and July 2018 as more packages were costed."
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: The additional costs came to approximately €15 million. It seems that this is a process failure.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: Mr. Quinn sat on the board. Was he on the board from the beginning?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: Mr. Quinn has seen it all. He saw what the board did or did not do. He saw all the failures about which we now know, as a result of the PwC and Mazars reports. We now have the benefit of hindsight. Mr. Quinn may not have had that at the time. Does he believe, in the context of his own membership of the board, that there may have been failings on his part, given that he was also head of...
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: Given that we have potentially lost €500 million, none of this is cheap.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: It is definite that there were process failures. People should be big enough to recognise that if there were failings on their part, those failings should be accepted and learned from. We say this to everybody who comes before us. There are many lessons to be learned from this project.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: I know the Secretary General has accepted that. I have two more questions and then I will be finished.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: That was stated several times at the health committee so I accept it. I know this was dealt with in the report on the conflicts of interest and the Secretary General responded by stating he stands over his view there were no conflicts of interest. Where in the PwC report does it state it was giving high level advice to the board on this project?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: Why not?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: No, we have it here that some of the PwC personnel involved in providing a high level input also formed part of the much larger team that conducted the review. Does Mr. McCarthy see this as something that should be declared and should at least be included in a report?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: Is it something Mr. McCarthy will be examining at some point?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: It strikes me there is something fundamentally wrong when it is not even acknowledged or declared. Conflicts of interest can be avoided if there is a declaration. There is not even a declaration. Questions were asked of Mr. Breslin and others when they were here previously regarding conflicts of interest and a relationship between PwC and this particular project. To my knowledge we were...
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
David Cullinane: It was well aware of that. Why were we not told?